Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYTLC Announces Dosing of First Patients in Part 2 of TLC590 Phase II Trial for Postsurgical Pain following BunionectomyPREV STORYBasilea at the 38th Annual J. P. Morgan Healthcare Conference – significant progress in Cresemba commercialization and R&D portfolio in 2019